221 related articles for article (PubMed ID: 32938850)
1. Clinical Utility of the Meal Tolerance Test in the Care of Patients with Type 2 Diabetes Mellitus.
Wakasaki H; Shono T; Nakao R; Yamamoto S; Minaga T; Fukuda S; Matsumoto R; Ohoshi T; Naka K; Nanjo K
Intern Med; 2020; 59(18):2229-2235. PubMed ID: 32938850
[TBL] [Abstract][Full Text] [Related]
2. Postprandial serum C-peptide to plasma glucose ratio as a predictor of subsequent insulin treatment in patients with type 2 diabetes.
Saisho Y; Kou K; Tanaka K; Abe T; Kurosawa H; Shimada A; Meguro S; Kawai T; Itoh H
Endocr J; 2011; 58(4):315-22. PubMed ID: 21415555
[TBL] [Abstract][Full Text] [Related]
3. C-peptide response to glucagon in type 2 diabetes mellitus: a comparison with oral glucose tolerance test.
Iwasaki Y; Kondo K; Hasegawa H; Oiso Y
Diabetes Res; 1994; 25(3):129-37. PubMed ID: 7671552
[TBL] [Abstract][Full Text] [Related]
4. 20/(fasting C-peptide × fasting plasma glucose) is a simple and effective index of insulin resistance in patients with type 2 diabetes mellitus: a preliminary report.
Ohkura T; Shiochi H; Fujioka Y; Sumi K; Yamamoto N; Matsuzawa K; Izawa S; Kinoshita H; Ohkura H; Kato M; Taniguchi S; Yamamoto K
Cardiovasc Diabetol; 2013 Jan; 12():21. PubMed ID: 23339473
[TBL] [Abstract][Full Text] [Related]
5. Serum free C-peptide response to oral glucose loading as a parameter for the monitoring of pancreatic B-cell function in diabetic patients.
Hsieh SD; Kanazawa Y; Akanuma Y
Diabetes Res Clin Pract; 1985 Aug; 1(2):109-14. PubMed ID: 3915258
[TBL] [Abstract][Full Text] [Related]
6. A study of serum free C-peptide responses to oral glucose load in diabetic patients: with special reference to types of diabetes and methods of treatment.
Hsieh SD; Akanuma Y; Takaku F
Tohoku J Exp Med; 1984 Mar; 142(3):249-60. PubMed ID: 6374968
[TBL] [Abstract][Full Text] [Related]
7. Correlation of serum CPR to plasma glucose ratio with various indices of insulin secretion and diseases duration in type 2 diabetes.
Okuno Y; Sakaguchi K; Komada H; Hashimoto N; Hirota Y; Nakamura T; Ogawa W; Seino S
Kobe J Med Sci; 2013 Apr; 59(2):E44-53. PubMed ID: 23756662
[TBL] [Abstract][Full Text] [Related]
8. The proinsulin/insulin (PI/I) ratio is reduced by postprandial targeting therapy in type 2 diabetes mellitus: a small-scale clinical study.
Ohkura T; Inoue K; Fujioka Y; Nakanishi R; Shiochi H; Sumi K; Yamamoto N; Matsuzawa K; Izawa S; Ohkura H; Kato M; Yamamoto K; Taniguchi S
BMC Res Notes; 2013 Nov; 6():453. PubMed ID: 24215809
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of second phase insulin secretion with simple surrogates derived from the mixed meal tolerance test in patients with type 2 diabetes.
Lian WC; Lin JD; Chang JB; Hsu CH; Pei C; Wu CZ; Hsieh CH; Pei D; Chen YL
Endocr J; 2013; 60(9):1077-84. PubMed ID: 23811986
[TBL] [Abstract][Full Text] [Related]
10. Parameters measuring beta-cell function are only valuable in diabetic subjects with low body mass index, high blood glucose level, or long-standing diabetes.
Lee SW; Lee S; Kim SH; Kim TH; Kang BS; Yoo SH; Lee MK; Koh WJ; Kang WS; Kim HJ
Yonsei Med J; 2011 Nov; 52(6):939-47. PubMed ID: 22028157
[TBL] [Abstract][Full Text] [Related]
11. Improved postprandial glycemic control with Humalog Mix75/25 after a standard test meal in patients with type 2 diabetes mellitus.
Malone JK; Woodworth JR; Arora V; Yang H; Campaigne BN; Hallé JP; Yale JF; Grossman LD
Clin Ther; 2000 Feb; 22(2):222-30. PubMed ID: 10743981
[TBL] [Abstract][Full Text] [Related]
12. Postprandial serum C-peptide to plasma glucose concentration ratio correlates with oral glucose tolerance test- and glucose clamp-based disposition indexes.
Okuno Y; Komada H; Sakaguchi K; Nakamura T; Hashimoto N; Hirota Y; Ogawa W; Seino S
Metabolism; 2013 Oct; 62(10):1470-6. PubMed ID: 23831440
[TBL] [Abstract][Full Text] [Related]
13. One-hour meal tolerance test to assess withdrawal of insulin therapy in overweight patients with type 2 diabetes.
Kumar D; Luna-Lollie T; Madha S
Endocr Pract; 2001; 7(4):256-61. PubMed ID: 11497476
[TBL] [Abstract][Full Text] [Related]
14. Alterations in Plasma Triglyceride Concentrations Following Two Oral Meals with Different Fat Content in Patients with Type 2 Diabetes Mellitus.
Gavra P; Melidonis A; Iraklianou S; Mihas C; Kolovou V; Mavrogeni S; Dimitriadis G; Rallidis L; Vasaramva K; Boutati E; Katsiki N; Kolovou G
Curr Vasc Pharmacol; 2018; 16(4):385-392. PubMed ID: 28552072
[TBL] [Abstract][Full Text] [Related]
15. The impact of insulin administration during the mixed meal tolerance test.
Besser RE; Jones AG; McDonald TJ; Shields BM; Knight BA; Hattersley AT
Diabet Med; 2012 Oct; 29(10):1279-84. PubMed ID: 22435709
[TBL] [Abstract][Full Text] [Related]
16. Metabolic effects of troglitazone therapy in type 2 diabetic, obese, and lean normal subjects.
Frias JP; Yu JG; Kruszynska YT; Olefsky JM
Diabetes Care; 2000 Jan; 23(1):64-9. PubMed ID: 10857970
[TBL] [Abstract][Full Text] [Related]
17. Effect of obesity on declining beta cell function after diagnosis of type 2 diabetes: a possible link suggested by cross-sectional analysis.
Saisho Y; Tanaka K; Abe T; Shimada A; Kawai T; Itoh H
Endocr J; 2012; 59(3):187-95. PubMed ID: 22156325
[TBL] [Abstract][Full Text] [Related]
18. Eight weeks of treatment with long-acting GLP-1 analog taspoglutide improves postprandial insulin secretion and sensitivity in metformin-treated patients with type 2 diabetes.
Gastaldelli A; Nauck MA; Balena R
Metabolism; 2013 Sep; 62(9):1330-9. PubMed ID: 23831441
[TBL] [Abstract][Full Text] [Related]
19. Impact of insulin sensitivity, beta-cell function and glycaemic control on initiation of second-line glucose-lowering treatment in newly diagnosed type 2 diabetes.
Rathmann W; Strassburger K; Bongaerts B; Bobrov P; Kuss O; Müssig K; Markgraf DF; Szendroedi J; Herder C; Roden M;
Diabetes Obes Metab; 2017 Jun; 19(6):866-873. PubMed ID: 28127851
[TBL] [Abstract][Full Text] [Related]
20. Insulin and C-peptide levels, pancreatic beta cell function, and insulin resistance across glucose tolerance status in Thais.
Chailurkit LO; Jongjaroenprasert W; Chanprasertyothin S; Ongphiphadhanakul B
J Clin Lab Anal; 2007; 21(2):85-90. PubMed ID: 17385686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
